Table 3.
Probability of 3-year survival.
| Number of patients | Overall survival (OS) | Progression free survival (PFS) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 3-Year probability (%) | 95% CI | p value | 3-Year probability (%) | 95% CI | p value | ||||
| Lower | Upper | Lower | Upper | ||||||
| Whole cohort | 127 | 76 | 67.8 | 84.2 | – | 71 | 62.2 | 79.8 | – |
| BEAM | 86 | 78.1 | 69.08 | 87.12 | 0.296 | 71.3 | 61.3 | 81.3 | 0.762 |
| BeEAM | 41 | 71 | 52.4 | 89.6 | 74.1 | 58.2 | 90.0 | ||
| Age | |||||||||
| ≤ 60 | 85 | 75.3 | 65.5 | 85.1 | 0.718 | 68.1 | 57.1 | 79.1 | 0.433 |
| > 60 | 42 | 76.6 | 61.1 | 92.1 | 77.3 | 63.2 | 91.4 | ||
| Sex | |||||||||
| Female | 46 | 76.3 | 63.4 | 89.2 | 0.815 | 68.5 | 54.2 | 82.8 | 0.953 |
| Male | 81 | 75.6 | 65.0 | 86.2 | 72.6 | 61.6 | 83.6 | ||
| Dx | |||||||||
| Hodgkin lymphoma/nodular sclerosis | 92 | 71.9 | 61.5 | 82.3 | 0.267 | 70.5 | 59.9 | 81.1 | 0.671 |
| All others | 35 | 84.7 | 72.4 | 97.0 | 71.4 | 55.5 | 87.3 | ||